SFI leader stabbed to death on college campus in Kerala

Bengaluru, Apr 21: An FIR has been filed against a Kannada TV anchor allegedly for organising a guest packed wedding at a resort near Bengaluru last week amid lockdown to contain the spread of coronavirus.

Police got the tip-off about the event held on April 18 by locals residing near the resort. Around 20 people were present there to attend the wedding.

The FIR has been filed under National Disaster Management Act (NDMA) and Section 188 and 269 of the Indian Penal Code.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.

Bengaluru, July 13: Chief Minister B S Yediyurappa on Monday made it clear that the government had no plans to extend the lockdown in Bengaluru Urban and Bengaluru Rural districts beyond July 22.  The two districts will enter a lockdown starting 8 pm on July 14. 

“There is no proposal before the government to extend the lockdown in Bengaluru Urban and Rural districts. The chief minister requests citizens not to panic and cooperate with the government without paying heed to rumours,” the Chief Minister’s Office (CMO) said. 

“The lockdown is being imposed to control the rising number of Covid-19 cases in these districts. The CM has instructed officials to make all arrangements in a week’s time and make ready whatever is necessary,” the CMO said. 

The clarification came after Yediyurappa chaired a meeting of the Covid-19 task force meeting. Yediyurappa also held a video conference with officials from all districts to review the Covid-19 situation, rainfall and irrigation measures. 

Two more districts - Dakshina Kannada and Dharwad - have decided to impose a lockdown to control the spread of Covid-19 following Yediyurappa’s video conference. Starting July 15, Dakshina Kannada will be under a lockdown for a week whereas it will be a 9-day lockdown in Dharwad. 

During his video conference, Yediyurappa noted that the number of cases was on the rise in Bengaluru, Dakshina Kannada, Dharwad, Ballari, Udupi and Kalaburagi. 

He further noted that Covid-19 fatalities were going up in Bidar, Dharwad, Gadag and Mysuru. He asked authorities to bring this under control. “Bidar is among five districts nationally when it comes to deaths. This has to be controlled,” Yediyurappa said, seeking a report by experts on this. 

Yediyurappa told authorities to prioritize rapid antigen tests. “One lakh test kits have been procured. Use them wisely in emergency cases,” the CM said. He ordered that those aged above 60 years, those with serious illnesses and showing symptoms of influenza-like illness (ILI) have to be identified and subjected to Covid-19 tests.